Clinical Trial Update: Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of entecavir with short-term intravenous hepatitis B immune globulin to prevent hepatitis B recurrence after l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Hepatitis B immune globulin

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatitis B, Liver Transplantation | Phase 4 | Status: UNKNOWN